Related Experiment Video
Updated: Jul 12, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
Preserving Timely Generic Drug Competition with Legislation on "Skinny Labeling"
S Sean Tu1, Aaron S Kesselheim2
1West Virginia University College of Law, Morgantown, West Virginia, USA.
Abstract:
Patents prevent generic drug entry. Brand firms file new "method of use" patents for old drugs to prevent generic entry. Congress addressed this issue by creating the "skinny label" pathway, which allows generic firms to use the drug label to indicate that the old drug can only be used for non-patented uses. This pathway is now in jeopardy due to a recent court case. This paper outlines the issues and suggests possible legislative solutions.
Related Concept Videos
Drug Nomenclature
Drug Regulation
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Bioequivalence: Overview
Drug Control Governance: Regulatory Bodies and Their Impact
Drug Elimination by Renal Route: Tubular Secretion

